Siga Technologies INC Operating Expenses
Siga Technologies INC (SIGA) reported Operating Expenses of $29.06 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-03-05
- Siga Technologies INC operating expenses for the quarter ending 2019-12-31 was $7.73M, a 8.76% increase year-over-year.
- Siga Technologies INC operating expenses for the quarter ending 2019-09-30 was $7.45M, a 92.71% decline year-over-year.
- Siga Technologies INC operating expenses for the quarter ending 2019-06-30 was $5.61M, a 11.90% decline year-over-year.
- Siga Technologies INC operating expenses for the quarter ending 2019-03-31 was $8.27M, a 31.58% increase year-over-year.
- Siga Technologies INC operating expenses for fiscal 2019 was $29.06M, a 76.17% decline from fiscal 2018.
- Siga Technologies INC operating expenses for fiscal 2018 was $121.95M, a 291.91% increase from fiscal 2017.
- Siga Technologies INC operating expenses for fiscal 2017 was $31.12M, a 32.36% decline from fiscal 2016.
- Siga Technologies INC operating expenses for fiscal 2016 was $46.00M, a 17.57% increase from fiscal 2015.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $15.18M derived: sum of 2 quarters · filed 2020-03-05 | $20.80M derived: sum of 3 quarters · filed 2020-03-05 | $29.06M 10-K · filed 2020-03-05 | |
| 2019-09-30 | $7.45M 10-Q · filed 2019-11-05 | $13.06M derived: sum of 2 quarters · filed 2019-11-05 | $21.33M 10-Q · filed 2019-11-05 | $28.44M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2019-06-30 | $5.61M 10-Q · filed 2019-08-06 | $13.88M 10-Q · filed 2019-08-06 | $20.99M derived: sum of 3 quarters · filed 2020-03-05 | $123.18M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2019-03-31 | $8.27M 10-Q · filed 2019-05-02 | $15.38M derived: sum of 2 quarters · filed 2020-03-05 | $117.57M derived: sum of 3 quarters · filed 2020-03-05 | $123.94M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $109.30M derived: sum of 2 quarters · filed 2020-03-05 | $115.67M derived: sum of 3 quarters · filed 2020-03-05 | $121.95M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $102.19M 10-Q · filed 2019-11-05 | $108.56M derived: sum of 2 quarters · filed 2019-11-05 | $114.84M 10-Q · filed 2019-11-05 | $121.13M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-06-30 | $6.37M 10-Q · filed 2019-08-06 | $12.65M 10-Q · filed 2019-08-06 | $18.94M derived: sum of 3 quarters · filed 2020-03-05 | $25.98M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-03-31 | $6.28M 10-Q · filed 2019-05-02 | $12.57M derived: sum of 2 quarters · filed 2020-03-05 | $19.61M derived: sum of 3 quarters · filed 2020-03-05 | $27.93M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2017-12-31 | $6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $13.32M derived: sum of 2 quarters · filed 2020-03-05 | $21.65M derived: sum of 3 quarters · filed 2020-03-05 | $31.12M 10-K · filed 2020-03-05 | |
| 2017-09-30 | $7.04M 10-Q · filed 2018-11-06 | $15.36M derived: sum of 2 quarters · filed 2018-11-06 | $24.84M 10-Q · filed 2018-11-06 | $38.60M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-06-30 | $8.32M 10-Q · filed 2018-08-07 | $17.79M 10-Q · filed 2018-08-07 | $31.56M derived: sum of 3 quarters · filed 2019-03-06 | $44.28M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | $9.47M 10-Q · filed 2018-05-04 | $23.24M derived: sum of 2 quarters · filed 2019-03-06 | $35.96M derived: sum of 3 quarters · filed 2019-03-06 | $47.14M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2016-12-31 | $13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $26.49M derived: sum of 2 quarters · filed 2019-03-06 | $37.67M derived: sum of 3 quarters · filed 2019-03-06 | $46.00M 10-K · filed 2019-03-06 | |
| 2016-09-30 | $12.72M 10-Q · filed 2017-11-07 | $23.91M derived: sum of 2 quarters · filed 2017-11-07 | $32.24M 10-Q · filed 2017-11-07 | $54.38M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-06-30 | $11.19M 10-Q · filed 2017-08-03 | $19.52M 10-Q · filed 2017-08-03 | $41.66M derived: sum of 3 quarters · filed 2018-03-06 | $46.61M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-03-31 | $8.33M 10-Q · filed 2017-05-04 | $30.47M derived: sum of 2 quarters · filed 2018-03-06 | $35.43M derived: sum of 3 quarters · filed 2018-03-06 | $41.23M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2015-12-31 | $22.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $27.10M derived: sum of 2 quarters · filed 2018-03-06 | $32.90M derived: sum of 3 quarters · filed 2018-03-06 | $39.13M 10-K · filed 2018-03-06 | |
| 2015-09-30 | $4.96M 10-Q · filed 2016-11-02 | $10.76M derived: sum of 2 quarters · filed 2016-11-02 | $16.99M 10-Q · filed 2016-11-02 | $35.38M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-06-30 | $5.80M 10-Q · filed 2016-08-08 | $12.03M 10-Q · filed 2016-08-08 | $30.43M derived: sum of 3 quarters · filed 2017-03-07 | $213.25M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2015-03-31 | $6.23M 10-Q · filed 2016-05-04 | $24.63M derived: sum of 2 quarters · filed 2017-03-07 | $207.45M derived: sum of 3 quarters · filed 2017-03-07 | $212.85M derived: sum of 4 quarters · filed 2017-03-07 | |
| 2014-12-31 | $18.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $201.22M derived: sum of 2 quarters · filed 2017-03-07 | $206.62M derived: sum of 3 quarters · filed 2017-03-07 | $212.81M 10-K · filed 2017-03-07 | |
| 2014-09-30 | $182.83M 10-Q · filed 2015-10-27 | $188.22M derived: sum of 2 quarters · filed 2015-10-27 | $194.41M 10-Q · filed 2015-10-27 | $201.86M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $5.40M 10-Q · filed 2015-08-04 | $11.58M 10-Q · filed 2015-08-04 | $19.03M derived: sum of 3 quarters · filed 2016-03-04 | $26.89M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | $6.19M 10-Q · filed 2015-05-06 | $13.64M derived: sum of 2 quarters · filed 2016-03-04 | $21.49M derived: sum of 3 quarters · filed 2016-03-04 | $28.09M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2013-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $15.30M derived: sum of 2 quarters · filed 2016-03-04 | $21.90M derived: sum of 3 quarters · filed 2016-03-04 | $29.04M 10-K · filed 2016-03-04 | |
| 2013-09-30 | $7.86M 10-Q · filed 2014-11-04 | $14.45M derived: sum of 2 quarters · filed 2014-11-04 | $21.59M 10-Q · filed 2014-11-04 | $29.36M derived: sum of 4 quarters · filed 2015-03-06 | |
| 2013-06-30 | $6.60M 10-Q · filed 2014-07-31 | $13.73M 10-Q · filed 2014-07-31 | $21.51M derived: sum of 3 quarters · filed 2015-03-06 | $29.19M derived: sum of 4 quarters · filed 2015-03-06 | |
| 2013-03-31 | $7.13M 10-Q · filed 2014-05-01 | $7.01M 10-K/A · filed 2013-05-15 | $14.91M derived: sum of 2 quarters · filed 2015-03-06 | $22.59M derived: sum of 3 quarters · filed 2015-03-06 | $31.63M derived: sum of 4 quarters · filed 2015-03-06 |
| 2012-12-31 | $7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $15.46M derived: sum of 2 quarters · filed 2015-03-06 | $24.49M derived: sum of 3 quarters · filed 2015-03-06 | $31.51M 10-K · filed 2015-03-06 | |
| 2012-09-30 | $7.69M 10-Q · filed 2013-11-06 | $16.72M derived: sum of 2 quarters · filed 2013-11-06 | $23.73M 10-Q · filed 2013-11-06 | $36.46M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-06-30 | $9.03M 10-Q · filed 2013-08-05 | $16.05M 10-Q · filed 2013-08-05 | $28.78M derived: sum of 3 quarters · filed 2014-03-10 | $38.40M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-03-31 | $7.01M 10-Q · filed 2013-05-15 | $19.74M derived: sum of 2 quarters · filed 2014-03-10 | $29.36M derived: sum of 3 quarters · filed 2014-03-10 | $42.96M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2011-12-31 | $12.73M derived: 10-K 12 month − 10-K/A 9 month · filed 2014-03-10 | $22.35M derived: sum of 2 quarters · filed 2014-03-10 | $35.95M derived: sum of 3 quarters · filed 2014-03-10 | $44.11M 10-K · filed 2014-03-10 | |
| 2011-09-30 | $9.62M 10-K/A · filed 2013-05-15 | $23.22M derived: sum of 2 quarters · filed 2013-05-15 | $31.38M 10-K/A · filed 2013-05-15 | $38.69M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-06-30 | $13.60M 10-K/A · filed 2013-05-15 | $21.76M 10-K/A · filed 2013-05-15 | $29.07M derived: sum of 3 quarters · filed 2013-05-15 | $38.11M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-03-31 | $8.16M 10-K/A · filed 2013-05-15 | $15.47M derived: sum of 2 quarters · filed 2013-05-15 | $24.51M derived: sum of 3 quarters · filed 2013-05-15 | $31.98M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2010-12-31 | $7.31M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $16.35M derived: sum of 2 quarters · filed 2013-05-15 | $23.82M derived: sum of 3 quarters · filed 2013-05-15 | $31.94M 10-K/A · filed 2013-05-15 | |
| 2010-09-30 | $9.04M 10-Q · filed 2011-11-08 | $16.51M derived: sum of 2 quarters · filed 2011-11-08 | $24.63M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $7.47M 10-Q · filed 2011-08-01 | $15.59M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $25.69M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |